Moreover, a recent study, demonstrating abnormal effectors and regulatory T cell subsets in pediatric-onset cases of MS, showed a prominent role of circulating pro-inflammatory CD8+CD161high MAIT cells in children with MS compared to controls [77]. The gene discussed is CD8A; the disease is myeloid sarcoma.